Decoy Therapeutics Inc. (DCOY)

US · Healthcare · Biotechnology

$1.13+0.88%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-2.4M

EPS

$-4.46

Market cap

$2.7M

P/E

0.1

Forward P/E

0.0

P/B

0.17

Book value

$8.12

EPS (TTM)

$12.74

52-week high

$38.40

52-week low

$0.90

50-day MA

$2.04

200-day MA

$5.37

Beta

0.74

Analysts rate Decoy Therapeutics Inc. a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $3.00.

Insiders

2.87%

Institutions

4.00%

Fund	Stake
Vanguard Capital Management, LLC	0.17%
Tower Research Capital LLC	0.01%
UBS Group AG	0.00%
Caitong International Asset Management Co., Limited.	0.00%
Morgan Stanley - Brokerage Accounts	0.00%
Advisory Services Network, LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Decoy Therapeutics Inc. — free to start.

Data updated 2026-11-07.